Back to STATE STREET CORP STATE STREET CORP

KROSKROS
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in KEROS THERAPEUTICS INC

STATE STREET CORP holds 541,193 shares of KROS (KEROS THERAPEUTICS INC), worth $5.8M as of 2026-Q2. The position was decreased (-3.7% shares). KROS represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$5.8M

Current Shares

541,193

Total Value Change

-$58.9M

Total Shares Change

-572,397

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
541,193
-3.7%
$5.8M0.0%$10.70
0
2026-Q1
Decreased
561,730
-47.8%
$6.2M0.0%$13.40
0
2025-Q4
Decreased
1.1M
-17.4%
$21.9M0.0%$20.27
0
2025-Q3
Decreased
1.3M
-5.9%
$20.6M0.0%$15.95
0
2025-Q2
Increased
1.4M
+6.3%
$18.5M0.0%$13.49
30
2025-Q1
Increased
1.3M
+8.2%
$13.3M0.0%$10.79
30
2024-Q4
Increased
1.2M
+8.1%
$19M0.0%$15.64
31
2024-Q3
Decreased
1.1M
-8.8%
$64.7M0.0%$56.45
0

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used